Live Webinar: Debating the Road Back to School
Experts discuss the pros and cons of reopening schools.
This webinar will feature the top minds in the field including:
Moderator: Kathleen Kenny, PharmD
Panelist: Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
Panelist: Paul Lipkin, MD
Kenny is president and CEO of Med Ink Exec, LLC. With over 20 years of clinical training and experience, Kenny believes that well-educated patients and knowledgeable practitioners both contribute to improved health outcomes.
Hallas is a clinical professor and director of the Pediatrics NP Program at New York University Meyers College of Nursing. She has presented nationally and internationally on her research that focuses on improving healthcare outcomes for vulnerable children in the pediatric populations. Her current research is on Vaccine Hesitancy and Vaccine Resistance in prenatal women and mothers of young children.
Lipkin is an associate professor of pediatrics at the Kennedy Krieger Institute (KKI) and the Johns Hopkins School of Medicine, as well as KKI’s director of Outpatient Medical Services. Dr. Lipkin’s clinical and research careers have focused on the early identification, evaluation, and treatment of children and adolescents with developmental disabilities, including autism, learning, and attention disorders.
Attendees can ask our panel questions during the webinar.
Don’t miss out on this must-attend event! Sign up here.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
